| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |